Clinical Trial Update: Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus [NA]

View source ↗

Summary

A completed pilot trial evaluating a three-drug regimen—Daclatasvir, Asunaprevir, and BMS-791325—with or without Ribavirin for Hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Asunaprevir (asunaprevir)
• BMS-791325
• Daclatasvir (daclatasvir)
• Ribavirin (ribavirin)

Snippet

Sponsor: Timothy Morgan, MD | Conditions: Hepatitis C | NA | Status: COMPLETED